Creative Details

Quality Score: 6/10

The advertisement promotes KRYSTEXXA, a treatment for adults with chronic refractory gout, highlighting potential risks such as anaphylaxis and infusion reactions.

Creative Information

CID:8b9e99eb-c6d0-4d0b-be1c-d0b5d50d5ebc
CRID:82_7402-939308
Domain:krystexxahcp.com
Seat:PP
Size:320x50
Bid:$4.11
Timestamp:11/4/2025, 4:53:50 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/4/2025, 7:02:14 PM5.75s
    adomain_analysissuccess11/4/2025, 7:49:49 PM3.37s
    adomain_capturesuccess11/4/2025, 7:48:03 PM0.10s
    ad_rendersuccess11/4/2025, 7:02:08 PM24.61s
    brand_mappingsuccess11/4/2025, 7:48:04 PM1.32s

    Analysis Results

    Ad Format: banner

    Brands: KRYSTEXXA

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:320x50
    Data Transferred:1668.61 KB
    Render Time:9.07 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1668.73 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js523.96
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/ads/studio/Enabler.js153.28
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://cdnjs.cloudflare.com/ajax/libs/gsap/latest/TweenMax.min.js105.43
    https://ad.doubleclick.net/ddm/adj/N2525149.3848558MATTERKIND/B32917492.427824543;dc_ver=106.314;dc_eid=40004001;sz=320x50;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=2742760;dc_adk=3706686476;ord=l6z6jv;click=https%3A%2F%2Fsjc-tr.contextweb.com%2Fbh%2Fct2%3Fi%3D0ahiNO5TJf2D~a%3D314269718cffc13418253dac077287421f7f33d5~agi%3D249856~ts%3Ds6YkQ5bIZS84Xfdzy3ayF6POcOx4Zt8W~es%3D2~c%3D2742760~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.sciencedaily.com%252Freleases%252F2025%252F10%252F251025084611.htm~s%3Dcontextweb.com~dt%3D4~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=d5YCm3wYIo;gcsr=m;stc=1;chaa=1;sttr=136;prcl=s99.70
    https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js93.74
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/9QfUaEVhl411vMX3VzLK1LlKytb3gkVkcXlQG2XWrlU.js52.10
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3